TNFRSF10B antibody (N-Term)
Quick Overview for TNFRSF10B antibody (N-Term) (ABIN636288)
Target
See all TNFRSF10B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Immunogen
- TRAIL receptor 2 antibody was raised in rabbit using N terminus of the human TRAIL-R2 protein as the immunogen.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal conditions should be determined byt he investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Serum containing 0.02 % Sodium Azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- TNFRSF10B (Tumor Necrosis Factor Receptor Superfamily, Member 10b (TNFRSF10B))
-
Alternative Name
- TRAIL Receptor 2
-
Background
- TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor (TNF) ligand family that rapidly induces apoptosis in a variety of transformed cell lines. A distinct receptor for TRAIL, TRAIL-R2 is widely expressed and the gene encoding TRAIL-R2 is located on human chromosome 8p22-21. TRAIL-R2 engages a caspase-dependent apoptotic pathway but, in contrast to TRAIL-R1, TRAIL-R2 mediates apoptosis via the intracellular adaptor molecule FADD/MORT1.
-
Pathways
- p53 Signaling, Apoptosis, Positive Regulation of Endopeptidase Activity
Target
-